Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 09-1994 | 06-1994 | 03-1994 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 719 | 1,279 | 2,668 |
| Marketable Securities | N/A | N/A | 5,000 | 5,000 | 0 |
| Other current assets | 0 | 0 | 104 | 84 | 27 |
| TOTAL | $N/A | $N/A | $5,823 | $6,363 | $2,695 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 112 | 94 | 74 |
| Other Non-Current Assets | 0 | 0 | 6 | 6 | 80 |
| TOTAL | $N/A | $N/A | $117 | $99 | $154 |
| Total Assets | $N/A | $N/A | $5,909 | $6,436 | $2,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 42 | 65 | 89 |
| TOTAL | $N/A | $N/A | $42 | $65 | $89 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $42 | $65 | $89 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 9,452 | 9,460 | 5,525 |
| Retained earnings | N/A | N/A | -3,746 | -3,251 | -2,949 |
| Other shareholders' equity | 0 | 0 | 67 | 67 | 67 |
| TOTAL | $N/A | $N/A | $5,867 | $6,371 | $2,737 |
| Total Liabilities And Equity | $0 | $0 | $5,909 | $6,436 | $2,826 |